

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | metanephric mesenchyme development (GO:0072075) | 6.56526835 |
| 2 | atrioventricular valve morphogenesis (GO:0003181) | 6.54371362 |
| 3 | protein heterotrimerization (GO:0070208) | 6.16585965 |
| 4 | cell proliferation involved in metanephros development (GO:0072203) | 6.00819898 |
| 5 | cell migration involved in heart development (GO:0060973) | 5.92047961 |
| 6 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 5.90450924 |
| 7 | kidney mesenchyme development (GO:0072074) | 5.89631233 |
| 8 | endocardial cushion morphogenesis (GO:0003203) | 5.83560800 |
| 9 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.67177507 |
| 10 | cell proliferation involved in kidney development (GO:0072111) | 5.38323741 |
| 11 | glomerular filtration (GO:0003094) | 5.30044325 |
| 12 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.25613046 |
| 13 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 5.10134433 |
| 14 | glomerulus development (GO:0032835) | 5.04397021 |
| 15 | positive regulation of calcium ion import (GO:0090280) | 4.93031884 |
| 16 | renal filtration (GO:0097205) | 4.92933349 |
| 17 | muscle filament sliding (GO:0030049) | 4.84417691 |
| 18 | actin-myosin filament sliding (GO:0033275) | 4.84417691 |
| 19 | mesenchyme morphogenesis (GO:0072132) | 4.77208566 |
| 20 | endothelium development (GO:0003158) | 4.37585290 |
| 21 | cGMP-mediated signaling (GO:0019934) | 4.33868745 |
| 22 | smooth muscle tissue development (GO:0048745) | 4.32921804 |
| 23 | glycoprotein catabolic process (GO:0006516) | 4.31555860 |
| 24 | actin-mediated cell contraction (GO:0070252) | 4.30231247 |
| 25 | activation of MAPKKK activity (GO:0000185) | 4.26614477 |
| 26 | extracellular fibril organization (GO:0043206) | 4.14567387 |
| 27 | mesenchymal cell development (GO:0014031) | 4.06701329 |
| 28 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 4.03309363 |
| 29 | positive regulation of smooth muscle cell migration (GO:0014911) | 4.02677335 |
| 30 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.98557233 |
| 31 | aorta morphogenesis (GO:0035909) | 3.94595476 |
| 32 | relaxation of smooth muscle (GO:0044557) | 3.91620788 |
| 33 | plasma membrane repair (GO:0001778) | 3.89861632 |
| 34 | muscle cell migration (GO:0014812) | 3.86215627 |
| 35 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.85300534 |
| 36 | cardiac epithelial to mesenchymal transition (GO:0060317) | 3.84940042 |
| 37 | myofibril assembly (GO:0030239) | 3.83380739 |
| 38 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.80912017 |
| 39 | positive regulation of metanephros development (GO:0072216) | 3.76219452 |
| 40 | germ cell migration (GO:0008354) | 3.74947476 |
| 41 | basement membrane organization (GO:0071711) | 3.71837553 |
| 42 | endodermal cell differentiation (GO:0035987) | 3.67989036 |
| 43 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.67264742 |
| 44 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.63558761 |
| 45 | sarcomere organization (GO:0045214) | 3.59734736 |
| 46 | negative regulation of protein localization to cell surface (GO:2000009) | 3.55758236 |
| 47 | endothelial cell morphogenesis (GO:0001886) | 3.51472349 |
| 48 | skin morphogenesis (GO:0043589) | 3.49961299 |
| 49 | positive regulation of DNA biosynthetic process (GO:2000573) | 3.49915595 |
| 50 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.46584861 |
| 51 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.41876451 |
| 52 | heart valve morphogenesis (GO:0003179) | 3.41746649 |
| 53 | regulation of skeletal muscle contraction (GO:0014819) | 3.41565772 |
| 54 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 3.40268478 |
| 55 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.38566308 |
| 56 | stem cell development (GO:0048864) | 3.37444195 |
| 57 | regulation of axon guidance (GO:1902667) | 3.36822268 |
| 58 | positive regulation of vascular permeability (GO:0043117) | 3.33296867 |
| 59 | fibril organization (GO:0097435) | 3.31821787 |
| 60 | myoblast fusion (GO:0007520) | 3.31129321 |
| 61 | skeletal muscle contraction (GO:0003009) | 3.30344965 |
| 62 | collagen fibril organization (GO:0030199) | 3.29219455 |
| 63 | tonic smooth muscle contraction (GO:0014820) | 3.28549429 |
| 64 | regulation of endothelial cell differentiation (GO:0045601) | 3.26839541 |
| 65 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.26677075 |
| 66 | glomerular basement membrane development (GO:0032836) | 3.23352390 |
| 67 | macroautophagy (GO:0016236) | 3.22766642 |
| 68 | actin filament-based movement (GO:0030048) | 3.19477600 |
| 69 | regulation of calcium ion import (GO:0090279) | 3.18825873 |
| 70 | actomyosin structure organization (GO:0031032) | 3.18594315 |
| 71 | regulation of cellular extravasation (GO:0002691) | 3.16714968 |
| 72 | lymph vessel development (GO:0001945) | 3.16035632 |
| 73 | striated muscle atrophy (GO:0014891) | 3.11743488 |
| 74 | patterning of blood vessels (GO:0001569) | 3.11642779 |
| 75 | response to BMP (GO:0071772) | 3.11210689 |
| 76 | cellular response to BMP stimulus (GO:0071773) | 3.11210689 |
| 77 | muscle cell fate commitment (GO:0042693) | 3.08176254 |
| 78 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.07262290 |
| 79 | keratan sulfate catabolic process (GO:0042340) | 3.07073209 |
| 80 | import into cell (GO:0098657) | 3.06265674 |
| 81 | hemidesmosome assembly (GO:0031581) | 3.05979628 |
| 82 | muscle cell cellular homeostasis (GO:0046716) | 3.04840439 |
| 83 | lymphangiogenesis (GO:0001946) | 3.04426903 |
| 84 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.04085056 |
| 85 | histamine transport (GO:0051608) | 3.03621218 |
| 86 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.03007495 |
| 87 | regulation of metanephros development (GO:0072215) | 3.01888003 |
| 88 | extracellular matrix assembly (GO:0085029) | 3.01760501 |
| 89 | enteric nervous system development (GO:0048484) | 2.99429282 |
| 90 | negative regulation of platelet activation (GO:0010544) | 2.99000795 |
| 91 | collagen metabolic process (GO:0032963) | 2.98960360 |
| 92 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.98038322 |
| 93 | response to inactivity (GO:0014854) | 2.97310508 |
| 94 | positive regulation of odontogenesis (GO:0042482) | 2.95976054 |
| 95 | collagen catabolic process (GO:0030574) | 2.94719968 |
| 96 | cardiac myofibril assembly (GO:0055003) | 2.94420535 |
| 97 | nephron tubule development (GO:0072080) | 2.93704749 |
| 98 | skeletal muscle tissue development (GO:0007519) | 2.93645415 |
| 99 | negative regulation of cartilage development (GO:0061037) | 2.92862042 |
| 100 | Notch receptor processing (GO:0007220) | 2.91785235 |
| 101 | chondrocyte proliferation (GO:0035988) | 2.87985975 |
| 102 | sprouting angiogenesis (GO:0002040) | 2.87333213 |
| 103 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.87206750 |
| 104 | myelination in peripheral nervous system (GO:0022011) | 2.86980309 |
| 105 | peripheral nervous system axon ensheathment (GO:0032292) | 2.86980309 |
| 106 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.84584832 |
| 107 | extracellular matrix disassembly (GO:0022617) | 2.83091279 |
| 108 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.81233493 |
| 109 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.81013286 |
| 110 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.80890518 |
| 111 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.78575675 |
| 112 | heart morphogenesis (GO:0003007) | 2.76094885 |
| 113 | nephron epithelium development (GO:0072009) | 2.76006246 |
| 114 | muscle organ development (GO:0007517) | 2.75523065 |
| 115 | bone trabecula formation (GO:0060346) | 2.75361806 |
| 116 | regulation of monocyte chemotaxis (GO:0090025) | 2.74679603 |
| 117 | iron ion import (GO:0097286) | 2.74390464 |
| 118 | neural crest cell development (GO:0014032) | 2.73432980 |
| 119 | multicellular organismal catabolic process (GO:0044243) | 2.72433915 |
| 120 | artery smooth muscle contraction (GO:0014824) | 2.71779108 |
| 121 | striated muscle contraction (GO:0006941) | 2.71759951 |
| 122 | dermatan sulfate biosynthetic process (GO:0030208) | 2.71742521 |
| 123 | renal tubule development (GO:0061326) | 2.71700581 |
| 124 | myoblast migration (GO:0051451) | 2.71137124 |
| 125 | negative regulation of receptor activity (GO:2000272) | 2.70292788 |
| 126 | negative regulation of gluconeogenesis (GO:0045721) | 2.70125895 |
| 127 | response to gravity (GO:0009629) | 2.69951954 |
| 128 | muscle structure development (GO:0061061) | 2.68693284 |
| 129 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.68366508 |
| 130 | desmosome organization (GO:0002934) | 2.68115566 |
| 131 | outflow tract morphogenesis (GO:0003151) | 2.67502699 |
| 132 | histamine secretion (GO:0001821) | 2.67164104 |
| 133 | positive regulation of astrocyte differentiation (GO:0048711) | 2.66611683 |
| 134 | * extracellular matrix organization (GO:0030198) | 2.66132963 |
| 135 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.65274882 |
| 136 | multicellular organismal metabolic process (GO:0044236) | 2.65250493 |
| 137 | * extracellular structure organization (GO:0043062) | 2.65143742 |
| 138 | positive regulation of phosphatase activity (GO:0010922) | 2.65138237 |
| 139 | muscle atrophy (GO:0014889) | 2.64740677 |
| 140 | regulation of smooth muscle cell migration (GO:0014910) | 2.64256544 |
| 141 | muscle tissue development (GO:0060537) | 2.62756917 |
| 142 | glomerular visceral epithelial cell development (GO:0072015) | 2.62001394 |
| 143 | virion attachment to host cell (GO:0019062) | 2.61782730 |
| 144 | adhesion of symbiont to host cell (GO:0044650) | 2.61782730 |
| 145 | axon extension involved in axon guidance (GO:0048846) | 2.61655951 |
| 146 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.61655951 |
| 147 | muscle cell proliferation (GO:0033002) | 2.61205013 |
| 148 | cell-substrate junction assembly (GO:0007044) | 2.61067671 |
| 149 | positive regulation of kidney development (GO:0090184) | 2.60250178 |
| 150 | regulation of sarcomere organization (GO:0060297) | 2.58388352 |
| 151 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.57911281 |
| 152 | response to muscle activity (GO:0014850) | 2.57803191 |
| 153 | dermatan sulfate metabolic process (GO:0030205) | 2.57526212 |
| 154 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.55951107 |
| 155 | cardiac muscle contraction (GO:0060048) | 2.55722532 |
| 156 | cell-matrix adhesion (GO:0007160) | 2.55233943 |
| 157 | vascular smooth muscle contraction (GO:0014829) | 2.55026622 |
| 158 | cardiac ventricle morphogenesis (GO:0003208) | 2.54518408 |
| 159 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.54387816 |
| 160 | induction of positive chemotaxis (GO:0050930) | 2.52639791 |
| 161 | ganglion development (GO:0061548) | 2.52278813 |
| 162 | response to increased oxygen levels (GO:0036296) | 2.48993875 |
| 163 | response to hyperoxia (GO:0055093) | 2.48993875 |
| 164 | positive regulation of catecholamine secretion (GO:0033605) | 2.48662702 |
| 165 | cardiac chamber morphogenesis (GO:0003206) | 2.47591290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.03201072 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.89120249 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.48372816 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.47428135 |
| 5 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.36260638 |
| 6 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.35867313 |
| 7 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34981341 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32613555 |
| 9 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.24170983 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.17701912 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.09975414 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.09731779 |
| 13 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.04684404 |
| 14 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.03269099 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.02531514 |
| 16 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.99930795 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.99586695 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.99586695 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99458453 |
| 20 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.88240306 |
| 21 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.85389542 |
| 22 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.83303011 |
| 23 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.83303011 |
| 24 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.83303011 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.82220661 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81727396 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.80088219 |
| 28 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.78105919 |
| 29 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.73719062 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73484190 |
| 31 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.73090105 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71658537 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.68746562 |
| 34 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.68004960 |
| 35 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.67497863 |
| 36 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.66997781 |
| 37 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64981323 |
| 38 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.62584879 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61752137 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59595938 |
| 41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58355054 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.58230278 |
| 43 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57351221 |
| 44 | TP53_16413492_ChIP-PET_HCT116_Human | 1.53820213 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48444102 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.47451934 |
| 47 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.46607336 |
| 48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.46302167 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.46272504 |
| 50 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45808179 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45803531 |
| 52 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45550077 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44549612 |
| 54 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.39987322 |
| 55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.36691779 |
| 56 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.29757915 |
| 57 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29577220 |
| 58 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29148308 |
| 59 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28428692 |
| 60 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24871583 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24739164 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24157276 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19272759 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19272759 |
| 65 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.16231958 |
| 66 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16202549 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15549919 |
| 68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15138278 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13684884 |
| 70 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12125713 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11871609 |
| 72 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11123968 |
| 73 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10757455 |
| 74 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09912933 |
| 75 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09529548 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08494731 |
| 77 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07221981 |
| 78 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07208692 |
| 79 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07183367 |
| 80 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07022999 |
| 81 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06706414 |
| 82 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.06685627 |
| 83 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.06597510 |
| 84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05403235 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05209383 |
| 86 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.04790177 |
| 87 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.04436181 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04363436 |
| 89 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04128537 |
| 90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03826547 |
| 91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03430576 |
| 92 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03148299 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00466362 |
| 94 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00285487 |
| 95 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.99655485 |
| 96 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.99407491 |
| 97 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99019648 |
| 98 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98268941 |
| 99 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.97925628 |
| 100 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97177328 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96782119 |
| 102 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.95712206 |
| 103 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.95225926 |
| 104 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94585131 |
| 105 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.94227192 |
| 106 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.93897711 |
| 107 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93841278 |
| 108 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93241704 |
| 109 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.92894680 |
| 110 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92531187 |
| 111 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91806620 |
| 112 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90695463 |
| 113 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.90356513 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90024520 |
| 115 | * NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.89290861 |
| 116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88589588 |
| 117 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86793805 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86793805 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.86580291 |
| 120 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.85836685 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85262507 |
| 122 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84151753 |
| 123 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83921663 |
| 124 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83921663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004272_abnormal_basement_membrane | 5.82871355 |
| 2 | MP0003279_aneurysm | 4.80652666 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.50624833 |
| 4 | MP0009278_abnormal_bone_marrow | 3.13479524 |
| 5 | MP0005503_abnormal_tendon_morphology | 3.01137668 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.95647873 |
| 7 | MP0003724_increased_susceptibility_to | 2.83662136 |
| 8 | MP0000767_abnormal_smooth_muscle | 2.68967240 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.64529725 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.47547305 |
| 11 | MP0002254_reproductive_system_inflammat | 2.44732532 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.37703229 |
| 13 | MP0005623_abnormal_meninges_morphology | 2.34622324 |
| 14 | MP0001879_abnormal_lymphatic_vessel | 2.32852077 |
| 15 | MP0005165_increased_susceptibility_to | 2.29099251 |
| 16 | MP0006054_spinal_hemorrhage | 2.28042512 |
| 17 | MP0001958_emphysema | 2.27301010 |
| 18 | MP0000751_myopathy | 2.09511523 |
| 19 | MP0005164_abnormal_response_to | 2.02535537 |
| 20 | MP0005595_abnormal_vascular_smooth | 2.02387816 |
| 21 | MP0000013_abnormal_adipose_tissue | 2.00563852 |
| 22 | MP0005171_absent_coat_pigmentation | 1.99788412 |
| 23 | MP0004087_abnormal_muscle_fiber | 1.98266599 |
| 24 | MP0005508_abnormal_skeleton_morphology | 1.97318279 |
| 25 | MP0005275_abnormal_skin_tensile | 1.90565655 |
| 26 | MP0003828_pulmonary_edema | 1.82934423 |
| 27 | MP0001542_abnormal_bone_strength | 1.82503408 |
| 28 | MP0010030_abnormal_orbit_morphology | 1.77068450 |
| 29 | MP0000759_abnormal_skeletal_muscle | 1.64389867 |
| 30 | MP0004036_abnormal_muscle_relaxation | 1.63271570 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.63236232 |
| 32 | MP0002269_muscular_atrophy | 1.62692641 |
| 33 | MP0004883_abnormal_blood_vessel | 1.61752494 |
| 34 | MP0000462_abnormal_digestive_system | 1.60264028 |
| 35 | MP0003091_abnormal_cell_migration | 1.58944633 |
| 36 | MP0002295_abnormal_pulmonary_circulatio | 1.57872767 |
| 37 | MP0005369_muscle_phenotype | 1.57595180 |
| 38 | MP0002106_abnormal_muscle_physiology | 1.53727720 |
| 39 | MP0004145_abnormal_muscle_electrophysio | 1.53104884 |
| 40 | MP0002009_preneoplasia | 1.50055258 |
| 41 | MP0005330_cardiomyopathy | 1.49748162 |
| 42 | MP0000762_abnormal_tongue_morphology | 1.48862480 |
| 43 | MP0000516_abnormal_urinary_system | 1.46812672 |
| 44 | MP0005367_renal/urinary_system_phenotyp | 1.46812672 |
| 45 | MP0002108_abnormal_muscle_morphology | 1.46617033 |
| 46 | MP0003045_fibrosis | 1.44083369 |
| 47 | MP0001346_abnormal_lacrimal_gland | 1.43877598 |
| 48 | MP0009250_abnormal_appendicular_skeleto | 1.43558566 |
| 49 | MP0003385_abnormal_body_wall | 1.41830121 |
| 50 | MP0003283_abnormal_digestive_organ | 1.41478823 |
| 51 | MP0005023_abnormal_wound_healing | 1.40013183 |
| 52 | MP0001661_extended_life_span | 1.36664083 |
| 53 | MP0002060_abnormal_skin_morphology | 1.35378188 |
| 54 | MP0004858_abnormal_nervous_system | 1.33937741 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.26495216 |
| 56 | MP0000733_abnormal_muscle_development | 1.21892196 |
| 57 | MP0009384_cardiac_valve_regurgitation | 1.21213663 |
| 58 | MP0000049_abnormal_middle_ear | 1.20558419 |
| 59 | MP0002128_abnormal_blood_circulation | 1.16821512 |
| 60 | MP0000003_abnormal_adipose_tissue | 1.15220524 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.13701216 |
| 62 | MP0002938_white_spotting | 1.13573032 |
| 63 | MP0003941_abnormal_skin_development | 1.12951185 |
| 64 | MP0005620_abnormal_muscle_contractility | 1.12174999 |
| 65 | MP0000749_muscle_degeneration | 1.10878477 |
| 66 | MP0005390_skeleton_phenotype | 1.07747278 |
| 67 | MP0009379_abnormal_foot_pigmentation | 1.06121898 |
| 68 | MP0003075_altered_response_to | 1.05138999 |
| 69 | MP0000747_muscle_weakness | 1.03644161 |
| 70 | MP0000613_abnormal_salivary_gland | 1.03319440 |
| 71 | MP0001614_abnormal_blood_vessel | 1.02521887 |
| 72 | MP0000534_abnormal_ureter_morphology | 1.02151575 |
| 73 | MP0010630_abnormal_cardiac_muscle | 1.01424789 |
| 74 | MP0004134_abnormal_chest_morphology | 1.00385057 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 0.99305532 |
| 76 | MP0002896_abnormal_bone_mineralization | 0.96702681 |
| 77 | MP0000579_abnormal_nail_morphology | 0.96668872 |
| 78 | MP0003137_abnormal_impulse_conducting | 0.96435750 |
| 79 | MP0002932_abnormal_joint_morphology | 0.93869774 |
| 80 | MP0008775_abnormal_heart_ventricle | 0.93458909 |
| 81 | MP0000383_abnormal_hair_follicle | 0.92943590 |
| 82 | MP0000163_abnormal_cartilage_morphology | 0.92699817 |
| 83 | MP0001270_distended_abdomen | 0.91462146 |
| 84 | MP0002925_abnormal_cardiovascular_devel | 0.90739904 |
| 85 | MP0006138_congestive_heart_failure | 0.90561417 |
| 86 | MP0003935_abnormal_craniofacial_develop | 0.89981585 |
| 87 | MP0000249_abnormal_blood_vessel | 0.88484418 |
| 88 | MP0005388_respiratory_system_phenotype | 0.88350839 |
| 89 | MP0002133_abnormal_respiratory_system | 0.88350839 |
| 90 | MP0003115_abnormal_respiratory_system | 0.87909809 |
| 91 | MP0000750_abnormal_muscle_regeneration | 0.87837750 |
| 92 | MP0002233_abnormal_nose_morphology | 0.87644439 |
| 93 | MP0002249_abnormal_larynx_morphology | 0.87575004 |
| 94 | MP0000343_altered_response_to | 0.87547699 |
| 95 | MP0004130_abnormal_muscle_cell | 0.86806083 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.86121976 |
| 97 | MP0005670_abnormal_white_adipose | 0.85997632 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.83873663 |
| 99 | MP0002933_joint_inflammation | 0.82301598 |
| 100 | MP0003950_abnormal_plasma_membrane | 0.82108258 |
| 101 | MP0004484_altered_response_of | 0.81324741 |
| 102 | MP0000538_abnormal_urinary_bladder | 0.79327850 |
| 103 | MP0001545_abnormal_hematopoietic_system | 0.78887908 |
| 104 | MP0005397_hematopoietic_system_phenotyp | 0.78887908 |
| 105 | MP0003942_abnormal_urinary_system | 0.78684178 |
| 106 | MP0002166_altered_tumor_susceptibility | 0.78673915 |
| 107 | MP0000647_abnormal_sebaceous_gland | 0.78545054 |
| 108 | MP0005385_cardiovascular_system_phenoty | 0.78436708 |
| 109 | MP0001544_abnormal_cardiovascular_syste | 0.78436708 |
| 110 | MP0009764_decreased_sensitivity_to | 0.78029524 |
| 111 | MP0002127_abnormal_cardiovascular_syste | 0.78017294 |
| 112 | MP0003755_abnormal_palate_morphology | 0.75914277 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.74904688 |
| 114 | MP0001299_abnormal_eye_distance/ | 0.74495568 |
| 115 | MP0004215_abnormal_myocardial_fiber | 0.73685426 |
| 116 | MP0002972_abnormal_cardiac_muscle | 0.72479273 |
| 117 | MP0005187_abnormal_penis_morphology | 0.72266766 |
| 118 | MP0004085_abnormal_heartbeat | 0.71848421 |
| 119 | MP0001851_eye_inflammation | 0.71586383 |
| 120 | MP0002098_abnormal_vibrissa_morphology | 0.71278658 |
| 121 | MP0000566_synostosis | 0.71101235 |
| 122 | MP0004233_abnormal_muscle_weight | 0.69720173 |
| 123 | MP0003448_altered_tumor_morphology | 0.69385047 |
| 124 | MP0001915_intracranial_hemorrhage | 0.68926877 |
| 125 | MP0002115_abnormal_skeleton_extremities | 0.68640153 |
| 126 | MP0002168_other_aberrant_phenotype | 0.67759940 |
| 127 | MP0002114_abnormal_axial_skeleton | 0.66627512 |
| 128 | MP0000432_abnormal_head_morphology | 0.64668615 |
| 129 | MP0000467_abnormal_esophagus_morphology | 0.64588956 |
| 130 | MP0002177_abnormal_outer_ear | 0.64141417 |
| 131 | MP0001243_abnormal_dermal_layer | 0.64081723 |
| 132 | MP0002116_abnormal_craniofacial_bone | 0.63185795 |
| 133 | MP0009053_abnormal_anal_canal | 0.60734039 |
| 134 | MP0000266_abnormal_heart_morphology | 0.58214045 |
| 135 | MP0002113_abnormal_skeleton_development | 0.56877523 |
| 136 | MP0000858_altered_metastatic_potential | 0.56875528 |
| 137 | MP0002234_abnormal_pharynx_morphology | 0.55837135 |
| 138 | MP0010771_integument_phenotype | 0.53365720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.66048176 |
| 2 | Popliteal pterygium (HP:0009756) | 5.55692051 |
| 3 | Aortic dissection (HP:0002647) | 5.13857287 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.78715482 |
| 5 | Atrophic scars (HP:0001075) | 4.65739789 |
| 6 | Aortic aneurysm (HP:0004942) | 4.63551887 |
| 7 | Short hallux (HP:0010109) | 4.62489226 |
| 8 | Ankle contracture (HP:0006466) | 4.62034600 |
| 9 | Distal arthrogryposis (HP:0005684) | 4.60408518 |
| 10 | Bone cyst (HP:0012062) | 4.57777306 |
| 11 | Round ear (HP:0100830) | 4.54525483 |
| 12 | Cerebellar dysplasia (HP:0007033) | 4.46669004 |
| 13 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 4.18400559 |
| 14 | Gowers sign (HP:0003391) | 4.09538281 |
| 15 | Neonatal short-limb short stature (HP:0008921) | 4.08544352 |
| 16 | Type II lissencephaly (HP:0007260) | 3.98266133 |
| 17 | Abnormality of dentin (HP:0010299) | 3.97685392 |
| 18 | Difficulty climbing stairs (HP:0003551) | 3.92656711 |
| 19 | Broad metatarsal (HP:0001783) | 3.90742613 |
| 20 | Amniotic constriction ring (HP:0009775) | 3.89066676 |
| 21 | Abnormality of placental membranes (HP:0011409) | 3.89066676 |
| 22 | Retinal atrophy (HP:0001105) | 3.88825582 |
| 23 | Type 1 muscle fiber predominance (HP:0003803) | 3.85916479 |
| 24 | Follicular hyperkeratosis (HP:0007502) | 3.76851833 |
| 25 | Fetal akinesia sequence (HP:0001989) | 3.75012887 |
| 26 | Cerebral aneurysm (HP:0004944) | 3.64785586 |
| 27 | Ulnar deviation of the wrist (HP:0003049) | 3.63521621 |
| 28 | Aplasia of the musculature (HP:0100854) | 3.59514747 |
| 29 | Buphthalmos (HP:0000557) | 3.51595260 |
| 30 | Fragile skin (HP:0001030) | 3.44006915 |
| 31 | Calcaneovalgus deformity (HP:0001848) | 3.43130104 |
| 32 | Pulmonary artery stenosis (HP:0004415) | 3.35976420 |
| 33 | Fatigable weakness (HP:0003473) | 3.32221979 |
| 34 | Abnormality of the neuromuscular junction (HP:0003398) | 3.32221979 |
| 35 | Abnormality of Sharpey fibers (HP:0100685) | 3.30226832 |
| 36 | Chondrocalcinosis (HP:0000934) | 3.27536702 |
| 37 | Retinal dysplasia (HP:0007973) | 3.25097543 |
| 38 | Type 2 muscle fiber atrophy (HP:0003554) | 3.16604872 |
| 39 | Soft skin (HP:0000977) | 3.12260391 |
| 40 | Nemaline bodies (HP:0003798) | 3.11674647 |
| 41 | Venous insufficiency (HP:0005293) | 3.09761608 |
| 42 | Pterygium (HP:0001059) | 3.07641196 |
| 43 | Malignant hyperthermia (HP:0002047) | 3.06335963 |
| 44 | Spinal rigidity (HP:0003306) | 3.03816884 |
| 45 | Fatigue (HP:0012378) | 3.02126555 |
| 46 | Increased connective tissue (HP:0009025) | 2.94246587 |
| 47 | Morphological abnormality of the middle ear (HP:0008609) | 2.93165949 |
| 48 | Thin ribs (HP:0000883) | 2.83552163 |
| 49 | Venous abnormality (HP:0002624) | 2.82111672 |
| 50 | Hypoplasia of the iris (HP:0007676) | 2.73563899 |
| 51 | Ulnar claw (HP:0001178) | 2.73069706 |
| 52 | Muscle fiber atrophy (HP:0100295) | 2.72154079 |
| 53 | Aortic regurgitation (HP:0001659) | 2.70339270 |
| 54 | Bladder diverticulum (HP:0000015) | 2.69133212 |
| 55 | Hypoplasia of the pons (HP:0012110) | 2.69071681 |
| 56 | Absent phalangeal crease (HP:0006109) | 2.66976469 |
| 57 | Hip contracture (HP:0003273) | 2.66657333 |
| 58 | Increased variability in muscle fiber diameter (HP:0003557) | 2.66573893 |
| 59 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.65331761 |
| 60 | Neoplasm of the lung (HP:0100526) | 2.63965790 |
| 61 | Mesomelia (HP:0003027) | 2.62533857 |
| 62 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.61560300 |
| 63 | Pseudobulbar signs (HP:0002200) | 2.60483296 |
| 64 | Wormian bones (HP:0002645) | 2.59476212 |
| 65 | Akinesia (HP:0002304) | 2.59254197 |
| 66 | Nonimmune hydrops fetalis (HP:0001790) | 2.57885030 |
| 67 | Limited hip movement (HP:0008800) | 2.57844506 |
| 68 | Muscle fiber inclusion bodies (HP:0100299) | 2.57230757 |
| 69 | Biconcave vertebral bodies (HP:0004586) | 2.56394231 |
| 70 | Slender build (HP:0001533) | 2.55181022 |
| 71 | Congenital glaucoma (HP:0001087) | 2.44658568 |
| 72 | Absent toe (HP:0010760) | 2.43551919 |
| 73 | Femoral bowing (HP:0002980) | 2.42494478 |
| 74 | Peritonitis (HP:0002586) | 2.41913558 |
| 75 | Abnormality of the pons (HP:0007361) | 2.41296876 |
| 76 | Megalocornea (HP:0000485) | 2.40196218 |
| 77 | Trismus (HP:0000211) | 2.40049235 |
| 78 | Right ventricular cardiomyopathy (HP:0011663) | 2.39535097 |
| 79 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.39067717 |
| 80 | Deformed tarsal bones (HP:0008119) | 2.38153652 |
| 81 | Dilatation of the ascending aorta (HP:0005111) | 2.37680962 |
| 82 | Hyporeflexia of lower limbs (HP:0002600) | 2.36584110 |
| 83 | Calf muscle hypertrophy (HP:0008981) | 2.35754874 |
| 84 | Shallow orbits (HP:0000586) | 2.34343284 |
| 85 | Aplasia cutis congenita (HP:0001057) | 2.34158374 |
| 86 | Vascular tortuosity (HP:0004948) | 2.33669693 |
| 87 | Infantile muscular hypotonia (HP:0008947) | 2.33618500 |
| 88 | Hypercalcemia (HP:0003072) | 2.33478342 |
| 89 | Generalized muscle weakness (HP:0003324) | 2.32655615 |
| 90 | Sudden death (HP:0001699) | 2.29634303 |
| 91 | Congenital, generalized hypertrichosis (HP:0004540) | 2.28335322 |
| 92 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.27523424 |
| 93 | Fibular hypoplasia (HP:0003038) | 2.26862371 |
| 94 | Gingival overgrowth (HP:0000212) | 2.26861370 |
| 95 | Hypoplastic ischia (HP:0003175) | 2.26460558 |
| 96 | Prominent supraorbital ridges (HP:0000336) | 2.26232755 |
| 97 | Abnormality of the ischium (HP:0003174) | 2.23196217 |
| 98 | Weak cry (HP:0001612) | 2.22130306 |
| 99 | Submucous cleft hard palate (HP:0000176) | 2.20211528 |
| 100 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.16960633 |
| 101 | Adactyly (HP:0009776) | 2.16691802 |
| 102 | Upper limb muscle weakness (HP:0003484) | 2.16410213 |
| 103 | Aneurysm (HP:0002617) | 2.14631426 |
| 104 | Abnormality of the calcaneus (HP:0008364) | 2.14542872 |
| 105 | Neoplasm of the respiratory system (HP:0100606) | 2.14100485 |
| 106 | Abnormal finger flexion creases (HP:0006143) | 2.11103081 |
| 107 | Muscular dystrophy (HP:0003560) | 2.10288718 |
| 108 | Osteolytic defects of the hand bones (HP:0009699) | 2.09003548 |
| 109 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09003548 |
| 110 | Scapular winging (HP:0003691) | 2.06745331 |
| 111 | Lipoatrophy (HP:0100578) | 2.06420705 |
| 112 | Cervical subluxation (HP:0003308) | 2.05243453 |
| 113 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.05147054 |
| 114 | Easy fatigability (HP:0003388) | 2.04980326 |
| 115 | Stroke (HP:0001297) | 2.04840114 |
| 116 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.04515510 |
| 117 | Preaxial foot polydactyly (HP:0001841) | 2.03397945 |
| 118 | Wrist flexion contracture (HP:0001239) | 2.02067010 |
| 119 | Benign neoplasm of the central nervous system (HP:0100835) | 2.00178895 |
| 120 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.99206791 |
| 121 | Tibial bowing (HP:0002982) | 1.96725397 |
| 122 | Arterial tortuosity (HP:0005116) | 1.96686581 |
| 123 | Mild short stature (HP:0003502) | 1.96651928 |
| 124 | Breech presentation (HP:0001623) | 1.96597111 |
| 125 | Entropion (HP:0000621) | 1.95494309 |
| 126 | Distal lower limb amyotrophy (HP:0008944) | 1.93935013 |
| 127 | Narrow nasal bridge (HP:0000446) | 1.93810264 |
| 128 | Metatarsus adductus (HP:0001840) | 1.93727327 |
| 129 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.91924096 |
| 130 | Short 4th metacarpal (HP:0010044) | 1.91924096 |
| 131 | Asymmetric septal hypertrophy (HP:0001670) | 1.91717278 |
| 132 | Bowel diverticulosis (HP:0005222) | 1.91391169 |
| 133 | Mitral valve prolapse (HP:0001634) | 1.90104803 |
| 134 | Mesangial abnormality (HP:0001966) | 1.89693726 |
| 135 | Ectopia lentis (HP:0001083) | 1.88466276 |
| 136 | Wide anterior fontanel (HP:0000260) | 1.87793026 |
| 137 | Neck muscle weakness (HP:0000467) | 1.87633600 |
| 138 | Distal lower limb muscle weakness (HP:0009053) | 1.87575725 |
| 139 | Craniofacial hyperostosis (HP:0004493) | 1.86920958 |
| 140 | Knee flexion contracture (HP:0006380) | 1.85742335 |
| 141 | Genu recurvatum (HP:0002816) | 1.85211232 |
| 142 | Keratoconus (HP:0000563) | 1.84852725 |
| 143 | Increased corneal curvature (HP:0100692) | 1.84852725 |
| 144 | Joint laxity (HP:0001388) | 1.84750654 |
| 145 | Delayed gross motor development (HP:0002194) | 1.84402488 |
| 146 | Blue sclerae (HP:0000592) | 1.84117453 |
| 147 | Muscle fiber splitting (HP:0003555) | 1.82256996 |
| 148 | Broad hallux (HP:0010055) | 1.80777642 |
| 149 | Abnormality of the calf musculature (HP:0001430) | 1.79682541 |
| 150 | Milia (HP:0001056) | 1.79468811 |
| 151 | Synostosis involving the elbow (HP:0003938) | 1.78950670 |
| 152 | Humeroradial synostosis (HP:0003041) | 1.78950670 |
| 153 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.78814627 |
| 154 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.77155237 |
| 155 | Ventricular tachycardia (HP:0004756) | 1.71448050 |
| 156 | Cranial hyperostosis (HP:0004437) | 1.70526789 |
| 157 | Stomach cancer (HP:0012126) | 1.70009763 |
| 158 | Generalized amyotrophy (HP:0003700) | 1.69381619 |
| 159 | Abnormal delivery (HP:0001787) | 1.68669941 |
| 160 | Hyperextensible skin (HP:0000974) | 1.66837886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 5.73191659 |
| 2 | PDGFRA | 4.42897811 |
| 3 | KIT | 4.42885940 |
| 4 | EPHA3 | 3.33596529 |
| 5 | STK10 | 3.21380042 |
| 6 | TTN | 3.16814158 |
| 7 | TIE1 | 3.02353578 |
| 8 | EPHB2 | 2.89763815 |
| 9 | DMPK | 2.88989157 |
| 10 | MARK3 | 2.88939307 |
| 11 | ZAK | 2.68891205 |
| 12 | FGFR4 | 2.41060268 |
| 13 | LIMK1 | 2.30964785 |
| 14 | EPHB1 | 2.18864065 |
| 15 | MAPK15 | 2.14755081 |
| 16 | MAPKAPK3 | 2.04282497 |
| 17 | TGFBR2 | 1.85881542 |
| 18 | PDGFRB | 1.85366764 |
| 19 | FRK | 1.83771447 |
| 20 | PAK2 | 1.81540749 |
| 21 | CDC42BPA | 1.75125082 |
| 22 | DDR2 | 1.61288622 |
| 23 | FER | 1.60121985 |
| 24 | BMPR1B | 1.56099540 |
| 25 | KDR | 1.47379187 |
| 26 | PIK3CG | 1.46907895 |
| 27 | ABL2 | 1.46872355 |
| 28 | IRAK1 | 1.44431713 |
| 29 | EEF2K | 1.39358016 |
| 30 | PIK3CA | 1.37018439 |
| 31 | TGFBR1 | 1.34497220 |
| 32 | MST1R | 1.32715052 |
| 33 | EPHA2 | 1.32388137 |
| 34 | RIPK1 | 1.31014858 |
| 35 | ADRBK1 | 1.30989002 |
| 36 | STK11 | 1.28327090 |
| 37 | FGFR2 | 1.27907053 |
| 38 | TRIB3 | 1.26423564 |
| 39 | PRKD2 | 1.25036703 |
| 40 | FGFR3 | 1.23795068 |
| 41 | MAP2K2 | 1.17507688 |
| 42 | MET | 1.15585889 |
| 43 | NUAK1 | 1.14529925 |
| 44 | LATS2 | 1.10740276 |
| 45 | ROCK1 | 1.04460441 |
| 46 | NLK | 1.03509005 |
| 47 | ILK | 1.00205612 |
| 48 | LATS1 | 0.99726836 |
| 49 | MUSK | 0.98912123 |
| 50 | TESK1 | 0.94903946 |
| 51 | MELK | 0.93077057 |
| 52 | MAP3K7 | 0.91471937 |
| 53 | INSRR | 0.89682370 |
| 54 | TRPM7 | 0.87687879 |
| 55 | ERN1 | 0.86179996 |
| 56 | MAP2K1 | 0.81133326 |
| 57 | PTK2B | 0.79747519 |
| 58 | MAPK7 | 0.79581478 |
| 59 | NEK9 | 0.79259450 |
| 60 | CAMK1 | 0.79112743 |
| 61 | GRK1 | 0.73200919 |
| 62 | PAK4 | 0.69261261 |
| 63 | MAP3K14 | 0.68940971 |
| 64 | CLK1 | 0.68873641 |
| 65 | MAPKAPK5 | 0.66197180 |
| 66 | CASK | 0.66043958 |
| 67 | MARK1 | 0.65499466 |
| 68 | STK38 | 0.64322251 |
| 69 | DAPK3 | 0.63500019 |
| 70 | PRKCE | 0.63377760 |
| 71 | PIM1 | 0.61161109 |
| 72 | JAK1 | 0.61116516 |
| 73 | NEK6 | 0.61089398 |
| 74 | ERBB3 | 0.61044961 |
| 75 | ADRBK2 | 0.60990063 |
| 76 | LMTK2 | 0.60030595 |
| 77 | ERBB2 | 0.59999410 |
| 78 | FLT3 | 0.58020417 |
| 79 | CDK8 | 0.57814083 |
| 80 | TSSK6 | 0.57267060 |
| 81 | CDK9 | 0.56646976 |
| 82 | PTK2 | 0.56590143 |
| 83 | HIPK2 | 0.55821097 |
| 84 | CAMK2D | 0.55692057 |
| 85 | CCNB1 | 0.55360187 |
| 86 | PRKCH | 0.54163841 |
| 87 | OBSCN | 0.53871275 |
| 88 | INSR | 0.53533776 |
| 89 | PNCK | 0.53362238 |
| 90 | STK3 | 0.51009737 |
| 91 | PTK6 | 0.50634017 |
| 92 | RPS6KA2 | 0.47645444 |
| 93 | CAMK2G | 0.46772725 |
| 94 | MTOR | 0.46714072 |
| 95 | STK39 | 0.46254937 |
| 96 | CAMK1D | 0.45935504 |
| 97 | SIK1 | 0.45346433 |
| 98 | STK38L | 0.44968074 |
| 99 | PRKD3 | 0.44083758 |
| 100 | MAP3K6 | 0.43569605 |
| 101 | JAK3 | 0.43309495 |
| 102 | PRKAA2 | 0.42753015 |
| 103 | CAMK1G | 0.41855974 |
| 104 | CAMK2A | 0.40965748 |
| 105 | ABL1 | 0.40860273 |
| 106 | ROCK2 | 0.39953378 |
| 107 | ERBB4 | 0.38598301 |
| 108 | RET | 0.38540215 |
| 109 | CDK3 | 0.36856963 |
| 110 | RPS6KA4 | 0.36308036 |
| 111 | GSK3A | 0.35805270 |
| 112 | MAP3K2 | 0.35178534 |
| 113 | CAMK4 | 0.34349265 |
| 114 | MAP3K3 | 0.33259511 |
| 115 | CAMK2B | 0.33167611 |
| 116 | MAPK4 | 0.31033681 |
| 117 | PHKG1 | 0.30563866 |
| 118 | PHKG2 | 0.30563866 |
| 119 | IGF1R | 0.30133741 |
| 120 | WNK1 | 0.29615701 |
| 121 | IRAK3 | 0.28688460 |
| 122 | PRKD1 | 0.28037790 |
| 123 | SGK494 | 0.27353317 |
| 124 | SGK223 | 0.27353317 |
| 125 | MOS | 0.26924364 |
| 126 | IKBKE | 0.26912030 |
| 127 | BCR | 0.26228946 |
| 128 | AKT3 | 0.25756135 |
| 129 | IRAK2 | 0.25745927 |
| 130 | PRKG2 | 0.24693319 |
| 131 | MAPK12 | 0.24097360 |
| 132 | RPS6KL1 | 0.24036955 |
| 133 | RPS6KC1 | 0.24036955 |
| 134 | MAPKAPK2 | 0.22805646 |
| 135 | TYK2 | 0.22804727 |
| 136 | PAK3 | 0.22269867 |
| 137 | EIF2AK2 | 0.22227457 |
| 138 | NTRK1 | 0.21467204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.34880441 |
| 2 | Focal adhesion_Homo sapiens_hsa04510 | 2.96435518 |
| 3 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.71192512 |
| 4 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.67500697 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.56538691 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.14477130 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.13097030 |
| 8 | Amoebiasis_Homo sapiens_hsa05146 | 2.04179395 |
| 9 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.91618874 |
| 10 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.89776483 |
| 11 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.82512272 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.78194994 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.71707626 |
| 14 | Adherens junction_Homo sapiens_hsa04520 | 1.69094748 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66974763 |
| 16 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.55583456 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.55342193 |
| 18 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.54465705 |
| 19 | Axon guidance_Homo sapiens_hsa04360 | 1.48817991 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42088368 |
| 21 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.40332627 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.38499643 |
| 23 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.37565254 |
| 24 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.36673807 |
| 25 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.34583933 |
| 26 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.34045315 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33636295 |
| 28 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.33473427 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.32016558 |
| 30 | Melanoma_Homo sapiens_hsa05218 | 1.28491658 |
| 31 | Pathways in cancer_Homo sapiens_hsa05200 | 1.26743882 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.26430134 |
| 33 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.23089097 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.17551839 |
| 35 | Tight junction_Homo sapiens_hsa04530 | 1.17016674 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16664344 |
| 37 | Prostate cancer_Homo sapiens_hsa05215 | 1.15848041 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.14549964 |
| 39 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.13884868 |
| 40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13318938 |
| 41 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.12656758 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07794721 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02961508 |
| 44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02167310 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01315022 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00375738 |
| 47 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.99702373 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98812329 |
| 49 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.98371340 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98271280 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96186939 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95012972 |
| 53 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.93649193 |
| 54 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.92863656 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90671130 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 0.84449214 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.84160354 |
| 58 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.83978757 |
| 59 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.83680524 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.82913822 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81867419 |
| 62 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.81602069 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80084249 |
| 64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80003840 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.78771619 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.77339786 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.77206218 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.77123615 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77094283 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77050477 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77001716 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.73723183 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.71691670 |
| 74 | Melanogenesis_Homo sapiens_hsa04916 | 0.70269579 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.70238247 |
| 76 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.69983315 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69793263 |
| 78 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.69102817 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67533330 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.67337215 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65060785 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64401368 |
| 83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64348601 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62721057 |
| 85 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62492024 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61188647 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.60896632 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.60602558 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59491484 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58874404 |
| 91 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58265266 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57502563 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57409434 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53546361 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53143209 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.51248286 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51242370 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51120213 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50528672 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.49783550 |
| 101 | Hepatitis B_Homo sapiens_hsa05161 | 0.49604759 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49270261 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49244423 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48235278 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46695635 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46419058 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45700623 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.44512737 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.44507874 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43859545 |
| 111 | Influenza A_Homo sapiens_hsa05164 | 0.43661426 |
| 112 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43358151 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43181676 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42348194 |
| 115 | Apoptosis_Homo sapiens_hsa04210 | 0.41828729 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41718367 |
| 117 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41127578 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40294358 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39904705 |
| 120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37907304 |
| 121 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37642647 |
| 122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37413783 |
| 123 | Cocaine addiction_Homo sapiens_hsa05030 | 0.35946041 |
| 124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35481615 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.35200190 |
| 126 | Long-term depression_Homo sapiens_hsa04730 | 0.35115922 |
| 127 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35107135 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34641043 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.31442101 |
| 130 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.30460257 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27555514 |
| 132 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.27234530 |
| 133 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.26508670 |

